73
DAFTAR PUSTAKA
Andreanne, G., Genevieve, C., Claude, P., 2011, Prevalence of Dyspepsia in COPD Patients : Experience in a Large Canadian Cohort, European Respiratory Journal, Volume 38 : 3480.
Anonim, 2015, Sejarah, Visi dan Misi, dan Pelayanan BBKPM Surakarta, bbkpmska.com , diakses 5 Desember 2016.
Aprilia, I., 2013, Gambaran Terapi dan Analisis Biaya Pasien Paru Obstruktif Kronik Rawat Inap RSUD Dr. Moewardi di Surakarta Tahun 2010-2011, Naskah Publikasi, Universitas Muhammadiyah Surakarta, Surakarta.
Ardestani, M.E., Kalantary, E., Samaiy, V., Taherian, K., 2017, Methyl prednisolone vs Dexamethasone in Management of COPD Exacerbations
; a Randomized Clinical Trial, Emergency, Volume 5(1) : e35.
Badan Penelitian dan Pengembangan Kesehatan (BPPK), 2013, Riset Kesehatan Dasar, 83-87, Kementerian Kesehatan Republik Indonesia, Jakarta.
Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS Kesehatan), 2014, Info BPJS Kesehatan, Edisi VII, 3, BPJS Kesehatan, Jakarta.
Barnes, P.J., 2003, Theophylline : New Perspectives for an Old Drug, American Journal of Respiratory and Critical Care Medicine, Volume 167(6) : 813-81.
Bourdet, S.V. & Williams, D.M., 2005, Chronic Obstructive Pulmonary Disease, dalam Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R.,Wells, B.G., Posey, L.M., Pharmacotherapy: A Pathophysiologic Approach, Sixth Edition, 537-552, McGraw-Hill Companies, USA.
Brijker, F., Heijdra, Y.F., van den Elshout, F.J., Folgering, H.T., 2002, Discontinuation of Furosemide Decreases PaCO2 in Patients with COPD, Chest, Volume 121(2) : 377-382.
Carrasco-Garido, P., de Miguel-Diez, J., Rejas-Gutierrez, J., Martin-Centeno, A., Gobartt-Vazquez, E., Hernandez-Barrera, V., de Miguil, A.G., Jimenez- Garcia, R., 2009, Characteristics of Chronic Obstructive Pulmonary Disease in Spain from a Gender Perspective, BMC Pulmonary Medicine, Volume 9(2).
Cavailles, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.C., Morel, H., Person-Tacnet, CC., Leroyer, C., Diot, P., 2013, Comorbidities of COPD, European Respiratory Review, Volume 22 : 454-475.
Cazzola, M., Calzetta, L., Page, C., Jardim, J., Chuchalin, A.G., Rogliani, P., Matera, M.G., 2015, Influence of N-acetylcysteine on Chronic Bronchitis or COPD Exacerbations : a Meta-analysis, European Respiratory Review, Volume 24 : 451-461.
Charlson, M.E., Pompei, P., Ales, K.L., 1987, A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies : Development and Validation, Journal Chronic Disease, Volume 40 : 373–383.
Chatila, M.W., Thomashow, B.M., Minai, O.A., Criner, G.J., Make, B.J., 2008, Comorbidities in Chronic Obstructive Pulmonary Disease, Proceedings of the American Thoracic Society, Volume 5(4) : 549-555.
Chick, T., Bone, R., Boyars, M., Braun, S.R., Buist, S., Campbell, S., Cohen, B.M., Conway, W., Cuggel, D.W., DeGraff, A.Jr., Friedman, M., George, R.B., Gershwin, E., Kram, J.A., Lakshminarayan, S., Levin, D.C., Petty, T.L., Rennard, S., Repsher, L., Sahn, S.A., Sandhaus, R., Serby, C.W., Simon, R.A., Tashkin, D., 1994, In Chronic Obstructive Pulmonary Disease, a Combination of Ipratropium and Albuterol is More Effective than either Agent Alone, Chest, Volume 105 : 1411-1419.
Dahlan, M.S., 2014, Statistik untuk Kedokteran dan Kesehatan, Epidemiologi Indonesia, Jakarta, Indonesia.
Dalal, A.A., Christensen, L., Liu, F., Riedel, A.A., 2010, Direct Costs of Chronic Obstructive Pulmonary Disease among Managed Care Patients, International Journal of Chronic Obstructive Pulmonary Disease, Volume 5 : 341-149.
Dringer, M.N., Edwards, D.F., Mattson, D.T., Akins, P.T., Sheedy, C.W., Hsu, C.Y., Dromerick, A.W., 1999, Predictors of Acute Hospital Cost for Treatment of Ischemic Stroke in an Academic Center, American Heart Association, Volume 30(4) : 724-728.
Durham, M.C., 2004, Tiotropium (Spiriva) : a Once Daily Inhaled Anticholinergic Medication for Chronis Obstructive Pulmonary Disease, BUMC Proceedings, Volume 17 : 366-371.
Ferreira, I.M., Brooks, D., Lacasse, Y., Goldstein, R.S., 2000, Nutritional Support for Individuals With COPD : a Meta-analysis, Chest Journal, Volume 117(3) : 672-8.
Fishman, A.P., 2008, Fishman’s Pulmonary Disease and Disorders, Fourth Edition, 741-743, McGraw-Hill, New York.
Ford, E.S., Murphy, L.B., Khavjou, O., Giles, W.H., Holt, J.B., Croft, J.B., 2015, Total and State-Specific Medical and Absenteeism Costs of COPD Among Adults Aged ≥ 18 Years in the United States for 2010 and Projections Through 2020, Chest Journal, Volume 147(1) : 3-5.
Gaude, G.S. & Nadagouda, S., 2010, Nebulized Corticosteroids in the Management of Acute Exacerbations of COPD, Lung India, Volume 27(4) : 230-235.
Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2010, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Updated 2010.
Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Updated 2014.
Guarascio, A.J., Ray, S.M., Finch, C.K., Self, T.H., 2013, The Clinical and Economic Burden of Chronic Obstructive Pulmonary Disease in the USA, ClinicoEconomics and Outcomes Research, 2013:5 235-245.
Hasanoglu, H.C., Yildirim, Z., Hasanoglu, A., Ozcan, C., Gokirmak, M., Koksal, N., Kalkan, S., 2003, Effects of Ranitidine on Pulmonary Function of Patients with Chronic Obstructive Pulmonary Disease, Pharmacological Research, Volume 47(6) : 535-539.
Hein, D., 2017, 5 Treatments Options for COPD Exacerbation, Medically Reviewed, www.healthline.com, diakses 8 Mei 2017.
Hilleman, D.E., Dewan, N., Malesker, M., Friedman, M., 2000, Pharmacoeconomic Evaluation of COPD, Chest Journal, Volume 118 : 1278-1285.
Hitchings, A.W., Archer, J.R., Srivastava, S.A., Baker, E.H., 2014, Safety of Metformin in Patients Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Melitus, Journal of Chronic Obstructive Pulmonary Disease, Volume 12(2) : 126-131.
Hudayani, M., 2016, Komparasi Biaya Riil dengan Tarif INA CBGs dan Analisis Komponen Biaya yang Berpengaruh pada Pasien Stroke Hemorargi Rawat Inap Peserta JKN di Rumah Sakit Kabupeten Pekalongan, Tesis, Pasca Sarjana Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.
Ikawati, Z, 2007, Farmakoterapi Penyakit Sistem Pernafasan, 65-2, Pustaka Adipura, Yogyakarta.
Jakovljevic, M., Lazic, Z., Verhaeghe, N., Jankovic, S., Gajovic, O., Annemans, S., 2013, Direct Medical Costs of COPD Diagnosis and Treatment, Eastern vs Western of Serbia and Belgium, Farmeconomia, Volume 14(4) : 161-168.
Jarad, N., 2011, Chronic Obstructive Pulmonary Disease (COPD) and Old Age?, Chronis Respiratory Disease, Volume 8(2) : 143-151.
Jatmiko, B.P., 2015, Kenaikan Biaya Kesehatan di Indonesia Lampaui Inflasi, bisniskeuangan.kompas.com, diakses 22 April 2016.
Kementerian Kesehatan Republik Indonesia (Kemenkes RI), 2013a, Pedoman Penerapan Kajian Farmakoekonomi, 1-3, Kementerian Kesehatan Republik Indonesia, Jakarta.
Kementerian Kesehatan Republik Indonesia (Kemenkes RI), 2013b, Buku Pegangan Sosialisasi Jaminan Kesehatan Nasional (JKN) dalam Sistem Jaminan Sosial Nasional, 16-18, 21-29, 40-43, Kementerian Kesehatan Republik Indonesia, Jakarta.
Khairina, S., 2014, Analisis Biaya dan Kesesuaian Biaya Riil dalam Penerapan Paket Tarif INA-CBG’s pada Pasien Asma di Instalasi Rawat Inap RSU Bina Kasih Ambarawa, Skripsi, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.
Leader, D., 2016, A Comprehensive Guide to COPD Complications, www.verywell.com, diakses 16 Mei 2016.
Lee, A.L. & Gooldstein, R.S., 2015, Gastroesophageal Reflux Disease in COPD : Links and Risks, International Journal of COPD, Volume 10 : 1935- 1949.
Lode, H., Eller, J., Linnhoff, A., Ioanas, M., 2004, Levofloxacin versus Clarithromicyn in COPD Exacerbations, European Respiratory Journal, Volume 24(6) : 947-953.
MacNee, W., 2000, Chronic Bronchitis and Emphysema, dalam Seaton A., Seaton, D., Leitch, A.G., Crofton and Douglas’s Respiratory Disease, Fifth Edition, 617-695, Blackwell Science Ltd, Oxford, UK.
Mannino, D.M., Higuchi, K., Tzy, C.Y., Zhou, H., Li, Y., Tian, H., Suh, K., 2015, Economic Burden of COPD in the Presence of Comorbidities, Chest Journal, Volume 148(1) : 138-150.
McDonald, C.F., 2014, Oxygen Therapy for COPD, Journal of Thoracic Disease, Volume 6(11) : 1632-1639.
Nannini, L.J., Lasserson, T.J., Poole, P., 2012, Combined Corticosteroid and Long-acting β2-agonist in One Inhaler versus Long-acting β2-agonist for Chronic Obstructive Pulmonary Disease, Cochrane Database of Systematic Reviews, Issue 9.Art.No.: CD006829, DOI : 10.1002/14651858.CD006829.pub2.
National Institute for Health and Care Excellence (NICE), 2010, Chronic Obstructive Pulmonary Disease in Over 16s : Diagnosis and Management, 10-15.
Pauwels, R.A., Lofdahl, C.G., Laitinen, L.A., Schouten, J.P., Postma, D.S., Pride, N.B., Ohlsson, S.V.,1999, Long-term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease who Continue Smoking, New England Journal of Medicine, Volume 340 : 1948-1953.
Perhimpunan Dokter Paru Indonesia (PDPI), 2011, PPOK (Penyakit Paru Obstruksi Kronis) : Diagnosis dan Penatalaksanaan, 5, Perhimpunan Dokter Paru Indonesia, Jakarta.
Poole, P,J., 2006, Role of Mucolytics in the Management of COPD, International Journal of COPD, Volume 1(2) : 123-128.
Putri, F., 2009, Analisis Biaya Penyakit Paru Obstruksi Kronis Pasien Rawat Inap RSUD Dr. Moewardi Surakarta berdasarkan Jenis Pembiayaan Periode Tahun 2008, Tesis, Pasca Sarjana Fakultas Farmasi Univeristas Gadjah Mada, Yogyakarta.
Raherison, C. & Girodet, P-O., 2009, Epidemiology of COPD, European Respiratory Review, Volume 18(114) : 213-221.
Ratto, D., Alfaro, C., Sipsey, J., Glovsky, M.M., Sharma, O.P., 1988, Are Intravenous Corticosteroids Required in Status Asthmaticus?, Journal of American Medical Association, Volume 260(4) : 527-529.
Saint, S., Bent, S., Vittinghoff, E., Grady, D., 1995, Antibiotics in Chronic Obstructive Pulmonary Disease Exacerbations : a Meta-analysis, The Journal of American Medical Association, Volume 273 : 957-960.
Sanchez, L.A., 2005, Pharmacoeconomics : Principles, Methods, and Applications, dalam Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R.,Wells, B.G., Posey, L.M., Pharmacotherapy: A Pathophysiologic Approach, Sixth Edition, 537-552, McGraw-Hill Companies, USA.
Sankar, V., Durga, K., Priya, K., Jose, S., Joseph, R.M., Thomas, P.M., 2016, Open Label Observational Comparative Efficacy Study of Ceftriaxone and Levofloxacin in COPD Exacerbations, Journal of Pharmacy Practice and Community Medicine, Volume 2(2) : 46-53.
Sidabutar, P., Rasmaliah, Hiswani, 2014, Karakteristik Penderita Penyakit Paru Obstruksi Kronik (PPOK) yang Dirawat Inap di RSUP H. Adam Malik Medan tahu 2012, Tugas Akhir, Fakultas Kesehatan Masyarakat Universitas Sumatera Utara, Medan.
Sulastomo, 2000, Manajemen Kesehatan, Cetakan III, 2-82, PT Gramedia Pustaka Utama, Jakarta.
Tarrichone, R., 2006, Cost Of Ilness Analysis. What Room in Health Economics?, Health Policy 77: 51-63
Thabrany, H, 2008, Sistem Pembiayaan dan Pembayaran Pelayanan Kesehatan, UI Press, Jakarta.
Vaz Fragoso, C.A., Miller, M.A., 1993, Review of the Clinical Efficacy of Theophylline in the Treatment of Chronic Obstructive Pulmonary Disease, American Review of Respiratory Disease, Volume 147 : 40-47.
Wiggins J., 1994, The Role of Anticholinergics in “Stable” Chronic Obstructive Pulmonary Disease : Unanswered Questions, Respiration, Volume 61 : 303–304.
Wilson, J.P., Rascati, K.L., 2001, Pharmacoeconomics, dalam Malone, P.M., Kier, K.L., Stanovich, J.E., Drug Information : a Guide for Pharmacists, Second Edition, 209-231, McGraw-Hill, New York.
World Bank, 2013, Pembiayaan Kesehatan di Indonesia : Peta Jalan Reformasi (Laporan), http://go.worldbank.org/FSZ8IWCTG0, diakses 22 April 2016.
World Health Organization (WHO), 2008a, World Health Statistics, 29-30.
World Health Organization (WHO), 2016b, COPD Management, www.who.int, diakses 13 Mei 2016.
Yamaya, M., Azuma, A., Takizawa, H., Kadota, J., Tamaoki, J., Kudoh, S., 2012, Macrolide Effects on the Prevention of COPD Exacerbations, European Respiratory Journal, Volume 40 : 485-494.
